Trade LRMR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Larimar Therapeutics, Inc. (LRMR) is trading at US$4.01, down 0.99% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$434.23M. Over the past 52 weeks, LRMR has traded between US$2.72 and US$6.42. On Syfe you can trade LRMR with $0 commission and add it to your watchlist.
| Previous close | US$4.05 |
|---|---|
| Market cap | US$434.23M |
| 52-week range | US$2.72 – US$6.42 |
| Volume | 641.47K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Year: 2020
Larimar Therapeutics Files First Module of BLA With US FDA for Nomlabofusp
Jun 29, 12:26 PM · MT Newswires
Top Premarket Decliners
Jun 29, 11:37 AM · MT Newswires
JPMorgan Initiates Larimar Therapeutics at Overweight With $9 Price Target
May 27, 10:42 AM · MT Newswires
Wedbush Adjusts Larimar Therapeutics Price Target to $12 From $13, Maintains Outperform Rating
May 15, 12:04 PM · MT Newswires
Larimar Therapeutics, Inc. (LRMR) stock is trading at US$4.01, -0.99% from the previous close of US$4.05.
The market cap for Larimar Therapeutics, Inc. (LRMR) stock is approximately US$434.23M.
The 52-week high for Larimar Therapeutics, Inc. (LRMR) stock is US$6.42.
The 52-week low for Larimar Therapeutics, Inc. (LRMR) stock is US$2.72.
Larimar Therapeutics, Inc. (LRMR) does not currently pay a dividend.
Stay on top of LRMR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
